B&K CORP-B (02396) announces its annual performance, with a net loss of 2.09 billion yuan, a year-on-year decrease of 1.5%.
Huaren Biology-B (02396) released its annual results for the year ending December 31, 2025. The group achieved revenue of 522,000 yuan, an increase of 100% compared to the previous year. It incurred a loss of 209 million yuan for the year, a decrease of 1.5% compared to the previous year. Loss per share was 2.08 yuan.
B&K CORP-B(02396) announced its annual performance for the period ending on December 31, 2025. The group achieved a revenue of 522,000 yuan, an increase of 100% compared to the previous year; a loss of 209 million yuan, a decrease of 1.5% compared to the previous year; and a loss per share of 2.08 yuan.
The announcement stated that the increase in revenue was mainly due to the sale of PDGF BB reagent for research and experiments to a single customer, which was a one-time sale. Providing research services and selling PDGF-BB reagent are not part of our core business.
Related Articles

GREENTOWN MGMT (09979) announces annual performance, with a net profit attributable to shareholders of 4.19 billion Yuan.

Anjoy Foods Group (02648) nominated Liu Mingming as a candidate for executive director of the sixth board of directors.

ANGELALIGN (06699) issued 123,800 restricted share units and 300,000 share purchase rights.
GREENTOWN MGMT (09979) announces annual performance, with a net profit attributable to shareholders of 4.19 billion Yuan.

Anjoy Foods Group (02648) nominated Liu Mingming as a candidate for executive director of the sixth board of directors.

ANGELALIGN (06699) issued 123,800 restricted share units and 300,000 share purchase rights.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


